Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?

MeSH terms

• Costs and Cost Analysis
• Drug Development / economics*
• Drug Industry / economics
• Drug Industry / legislation & jurisprudence
• Drug and Narcotic Control*
• Financial Management* / methods
• Financial Management* / organization & administration
• Financing, Government / organization & administration*
• Health Services Accessibility* / economics
• Health Services Accessibility* / organization & administration
• Health Services Needs and Demand
• Humans
• Policy Making
• Prescription Drugs / economics*
• United States